Antithrombin III Screen Kit
510(k) K812215
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK812215 | Date1 Sep 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JBQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.7060
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Antithrombin III Screen Kit is an in vitro diagnostic device classified as a quantitation reagent for measuring antithrombin III levels in plasma. It is designed to assist in the diagnosis and monitoring of conditions associated with antithrombin deficiency, such as hereditary antithrombin deficiency or acquired antithrombin deficiency, which may predispose patients to thrombotic events. The kit provides quantitative results to evaluate coagulation function and support clinical decision-making in hematology.
This kit is supplied as a single-use reagent system for laboratory use, requiring no special storage conditions beyond refrigeration at 2–8°C. It is intended for use in clinical laboratories with appropriate instrumentation, such as coagulation analyzers, and adheres to FDA 510(k) clearance under the Hematology advisory committee. The product code JBQ and regulation number 864.7060 further classify it as a Class II device under the FDA’s regulatory framework. No MRI safety considerations apply, as it is not intended for use in magnetic resonance environments.
Other devices from Pacific Hemostasis
Questions
AI-generated answers, 1 Oct 2026
What is the Antithrombin III Screen Kit used for?
The Antithrombin III Screen Kit is designed to measure antithrombin III levels in plasma, helping clinicians diagnose and monitor conditions like hereditary or acquired antithrombin deficiency. These deficiencies can increase the risk of thrombotic events, so accurate quantitation supports informed decision-making in hematology.
How is the Antithrombin III Screen Kit supplied and stored?
The kit is supplied as a single-use reagent system intended for laboratory use. It requires standard refrigeration between 2–8°C and does not need additional storage precautions. This ensures stability and reliability for quantitative testing in clinical settings.
Is the Antithrombin III Screen Kit intended for reuse or single-use?
The kit is explicitly designed for single-use only. This prevents cross-contamination and maintains accuracy in measuring antithrombin III levels, adhering to best practices for in vitro diagnostic devices.
What type of instrumentation is required to use the Antithrombin III Screen Kit?
The kit is intended for use in clinical laboratories equipped with coagulation analyzers. These analyzers are standard in hematology settings and ensure precise quantitation of antithrombin III, enabling reliable clinical assessment.
Does the Antithrombin III Screen Kit have any special regulatory considerations?
The kit holds FDA 510(k) clearance under the Hematology advisory committee and is classified as a Class II device (product code JBQ, regulation number 864.7060). No MRI safety concerns apply, as it is not intended for use in magnetic resonance environments.